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Oesophageal cancer is the seventh most commonly occurring cancer
(572.000 new cases in 2018) and the sixth leading cause of cancer death
(509.000 deaths in 2018) worldwide (Bray et al., 2018). Whenever possible,
oesophageal resection and reconstruction (oesophagectomy) is currently the
recommended treatment modality (Best, Mughal, & Gurusamy, 2016), but
carries a high risk of postoperative complications that impact patient quality
of life, cancer recurrence/survival, hospital costs and resources. Most of the
complications in patients undergoing oesophagectomy (e.g., atrial fibrilla -
tion, pneumonia) affect the cardiopulmonary system (Oxenberg, 2018).
Exercise results in a greater cardiac output, improved respiratory muscle
strength and skeletal muscle adaptations (Rivera-Brown & Frontera, 2012).
Exercise as part of prehabilitation (i.e. the process of providing patients with
a reserve to withstand the stress of major cancer surgery; Wynter-Blyth &
Moorthy, 2017) has been proposed to counteract the surgical consequences
of anaesthesia, tissue trauma and bed-rest (Vermillion et al., 2018). Several
studies on prehabilitation in patients undergoing thoracic and gastrointes -
tinal cancer resection have demonstrated an increase in preoperative
physical fitness and physical activity, as well as decreased postoperative
complications with shorter hospital stay (for some recent reviews see
Doganay & Moorthy, 2019; Vermillion et al., 2018).
Many potentially effective prehabilitation interventions may not
succeed, simply because patients fail to adopt and maintain the prescribed
behaviour (viz. regular exercise). The development of a theoretical unders -
tanding of the likely process of change, drawn on existing evidence and
theory, has been advocated as an integral step in complex intervention (i.e.
interventions that contain several interacting components; Craig et al.,
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2007) design and evaluation by the UK Medical Research Council (Craig
et al., 2007; Glanz & Bishop, 2010). However, choosing a relevant theory
(among many theories) can be a challenging task. Despite controversial
(see Odgen, 2016), a comprehensive supra-theory model of behaviour
applicable across contexts might be useful in behavioural intervention
design and evaluation. 
According to COM-B model (Michie, Campbell, West, Brown, &
Gainforth, 2014), for any behaviour to occur (B) at a given moment, there
must be the capability (C; i.e. psychological and physical abilities to
perform a behaviour) and opportunity (O; i.e. physical and social
environmental factors that facilitate engagement in the behaviour), and the
strength of motivation (M; i.e. reflective and automatic brain processes
that energise and direct behaviour) to engage in it must be greater than for
any competing behaviours. The model was developed to guide unders -
tanding of behaviour in context and to present behavioural determinants
targets for intervention design. Moreover, it sits at the centre of the
Behaviour Change Wheel (BCW; Michie, Atkins, & West, 2014) which is
a framework proposed to help intervention designers move from a
behavioural analysis of the problem (i.e. what needs to shift in order for
the desired behaviour to occur?) to intervention design (i.e. how can it be
effectively done: relevant intervention functions, behaviour change
techniques, mode of delivery?). The application of BCW to the develop -
ment of complex interventions has increased in popularity over recent
years (e.g. Barker, Atkins, & Lusignan, 2016; McEvoy et al., 2018).
A preoperative personalised programme (my-PEP [A more detailed
description of my-PEP can be found in the ExPO Trial Protocol –
available from the corresponding author)] was designed by a multidisci -
plinary team (e.g. physiotherapists, clinicians, psychologists) to increase
physical fitness in adults with oesophageal adenocarcinoma during the
preoperative phase (a period of approximately 14-16 weeks). This
prehabilitation intervention was theoretically grounded in BCW and
comprised two major components: exercise and psychological support to
adopt and maintain the prescribed exercise. The exercise component
consisted of home-based inspiratory muscle training with a device (up to
20 min per day), during and after neoadjuvant chemotherapy, and hospital-
supervised sessions of aerobic exercise and muscle strengthening (60 to
90-min sessions, 2 sessions per week for 4 weeks), after neoadjuvant
562
MELHORAR O BEM-ESTAR GLOBAL ATRAVÉS DA PSICOLOGIA DA SAÚDE
chemotherapy. The psychological component was operationalised through
behaviour change techniques and delivered before and during hospital-
supervised exercise sessions. In addition, both components were tailored
to patient’s capability (e.g., knowledge, skills, stamina), opportunity (e.g.,
time, social support) and motivation (e.g., desires, reflex responses,
evaluations, self-conscious planning) needs, formally assessed by
questionnaire and interview at baseline. Therefore, for instance, a frail
patient with low self-efficacy and a discouraging environmental context to
exercise was offered a prehabilitation intervention with suitable intensity
and duration levels of exercise, as well as a set of behaviour change
techniques aimed at creating more positive self-beliefs about capabilities
(e.g., focus on past success, social comparison, verbal persuasion about
capability) and increasing opportunity (e.g., restructuring physical
environment, use of prompts/cues). 
The purpose of this paper is to present feasibility data of my-PEP that
will potentially justify and inform a future randomised controlled trial to
determine if this prehabilitation intervention decreases postoperative
cardiopulmonary complications.
METHOD
A single centre, parallel group, single-blinded, randomised controlled
trial (NCT02962219) was carried out to produce primary (viz. patients’
eligibility; trial recruitment and retention; my-PEP adherence and safety)
and secondary (viz. reasons for non-participation in the study; group
differences in physical activity, physiological fitness, quality of life,
postoperative cardiopulmonary complications [This measure was used to
provide information about my-PEP safety rather than its efficacy])
outcomes and conducted in the department of Upper Gastrointestinal
Surgery at the Norfolk and Norwich University Hospitals Foundation
Trust (NNUH), Norwich, United Kingdom.
Participants
Adult patients with histology proven oesophageal adenocarcinoma
planned for both neoadjuvant chemotherapy and oesophagectomy, capable
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of giving informed consent and complying with trial procedures (e.g.
without concomitant illness or disability that would make them unsuitable
for exercise).
Material
In order to determine any changes in physical activity, physiological
fitness and quality of life over time, measurements were taken both prior
to commencement of neoadjuvant chemotherapy and one week prior to
surgery, using a few questionnaires – International Physical Activity
Questionnaire short version (IPAQ), European Organization for Research
and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC
QLQ-C30), EORTC QLQ Oesophago-Gastric module (EORTC QLQ-
OG25) – and a cardiopulmonary exercise (CPEX) test that would provide
measures of fitness [Fitness was operationalised as VO2peak – the maximal
oxygen consumed at peak exercise – and VO2AT – oxygen consumed at
estimated anaerobic threshold]. For the purpose of comparing groups of
patients (viz. willing vs. not willing to join the trial, intervention vs.
control) sociodemographic and clinical data were collected by a pseudo-
anonymised form – ExPO Patient Recruitment Identification Form (PRIF)
– at recruitment. Determinants of Physical Activity Questionnaire (DPAQ)
was used at baseline so that patients allocated in the intervention arm
could have their personal barriers and facilitators to perform physical
activity addressed or encouraged during my-PEP. A diary was also given
to these patients to record home-based exercise sessions adherence and
adverse reactions. Thirty-day postoperative morbidity was measured by
hand review of the medical notes.
Procedure
Patients were identified at weekly NNUH oesophagogastric cancer
specialist multidisciplinary team meetings between October 2016 and
June 2017. Written informed consent was obtained from the patients who
met the inclusion criteria. Consenting participants were asked to complete
PRIF, IPAQ, EORTC QLQ-C30 and -OG25, and to perform a CPEX prior
to commencement of neoadjuvant chemotherapy. Based on CPEX results,
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participants were stratified into high and low fitness score groups (to help
equally distribute those with a low level of fitness between trial arms,
reducing the risk of selection bias) and randomised afterwards.
Randomisation was done by a statistician on a 1:1 basis into intervention
and control arms using random block sizes (known only to the statistician)
generated by computerised randomisation. Both arms received usual
standard care advice (in written form) to exercise at home during the
preoperative phase. In addition to this, patients allocated in the
intervention arm were offered my-PEP components (based on DPAQ
results) and given the exercise diary. One week prior to surgery, all
participants were asked to complete the second IPAQ, EORTC QLQ-C30
and -OG25, and to perform another CPEX. After oesophagectomy 30-day
postoperative morbidity measurement was taken for all patients.
All statistical analyses were performed using a standard software
package (Stata v.15.0). Descriptive statistics were generated for
participants in each of the two arms (absolute frequencies and percentages
for categorical variables; means and standard deviations or medians and
interquartile ranges for continuous variables, depending on their
distributions). Equivalence between groups, regarding sociodemographic
and clinical data, was attested by means of Fisher exact test (or its
Freeman-Halton extension, for 2x3 contingency table) and Student test.
Mean differences between groups, concerning pretest to post-test changes,
were compared using Student test. All tests were two-tailed and the
significance was set at p≤.05.
RESULTS
Primary outcomes 
During the recruitment period, 20 eligible patients were approached
but only 11 were recruited (recruitment rate: 55%) because 7 did not want
to participate for different reasons (e.g. unwilling to travel for hospital
sessions, no need of additional support to engage in exercise, dislike for
exercise) and 2 patients who were willing to participate were excluded as
CPEX testing was unable to be arranged. The sociodemographic and
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clinical characteristics of both willing and non-willing patients were
similar [The details of this comparison can be found elsewhere (Lam,
2018)].
Table 1
Baseline sociodemographic and clinical characteristics of the allocated
participants
Note. nintervention=5 and ncontrol=6. N=Never, F=Former, C=Current, BMI=Body Mass Index,
CAD=Coronary Artery Disease, Ht=Hypertension. Data shown are f (%) or M±SD.
All recruited patients were randomised (5 to the intervention group, 6
to the control group; see Table 1) after providing consent for participation
and completed the trial (retention rate: 100%). The hospital-supervised
exercise sessions offered (Mdn=5, IQR=4-5) were fully attended
(attendance rate: 100%) by the intervention group who adhere completely
to the personalised aerobic and muscle strengthening exercises (adherence
rate: 100%). It was not feasible to offer the maximum 8 sessions to any of
the patients, due to the earlier than anticipated scheduling of either surgery
or second CPEX test. Adherence to home-based exercise sessions (i.e.
inspiratory muscle training and exercise according to standard care advice)
in the intervention group was low (adherence rate: 25% to 49%), owing to
the side effects of chemotherapy (viz. fatigue; nausea and vomiting; mouth
problems such as “dry mouth”, “mouth ulcers”, “cold sores”). No adverse
reactions to exercise were reported.
Secondary outcomes
Despite promising gains in intervention group’s physical activity,
physiological fitness and quality of life (see Table 2), there were no
statistically significant differences between arms regarding these variables
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(.12≥p≥.61). The 30-day postoperative cardiopulmonary complication
rates were also similar between arms (viz. intervention group: 60%;
control group: 67%). No deaths occurred at 30 days.
Table 2
Baseline values and changes in secondary outcome variables of the
allocated participants
Note. nintervention=5 and ncontrol=6. MET=Multiples of the resting metabolic rate. Data shown are
M±SD.
DISCUSSION
These findings provided ‘proof of concept’ for a larger feasibility
randomised controlled trial. Firstly, all patients referred for neoadjuvant
chemotherapy and oesophagectomy were eligible for the trial, could be
recruited in reasonable numbers and engaged easily until the end of the
study period. Secondly, my-PEP exercise sessions were safe and well
tolerated, with no significant adverse effects reported during the intervention
or after the oesophagectomy, and patients adhered particularly well to the
hospital-based sessions. At last, whilst there were important improvements
in intervention group’s physical activity, physiological fitness and quality of
life, this study was unable to demonstrate statistically significant differences
due to small patient numbers. 
Strengths of this study included the design of a programme tailored to
each patient’s (physical, psychological and environmental) needs, which
also had the input of both professionals and patients. Weakness of this
study comprised a small sample size (due to a much lower than anticipated
number of oesophagectomies over the recruitment period and logistic
problems with arranging baseline CPEX testing for potential participants
who wanted to join the trial) and its single centre nature (i.e., patients from
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Norfolk may not be representative of those in other areas of the UK,
particularly from more urban areas, limiting generalisation of the study
conclusions).
On that account, a larger sample from several centres will be required
in a definitive feasibility randomised controlled trial. Additional measures
to improve recruitment in future work could include (1) the capacity to
offer supervised exercise sessions closer to patients’ homes (e.g., in
primary care centres), as a long travel distance was the commonest reason
for non-participation, and (2) an alternative method of measuring
physiological fitness (e.g., 6-minute walk test; American Thoracic Society,
2002) to avoid CPEX laboratory logistic issues. Also, adherence to home-
based exercise sessions may also benefit from a more regular support or
contact from the trial team – through weekly telephone calls, for example
(Wynter-Blyth & Moorthy, 2017).
In sum, it was demonstrated that my-PEP is viable, safe and well
adhered to, but needs a larger feasibility study in patients with oesophageal
adenocarcinoma undergoing chemotherapy to investigate whether their
fitness can be improved in the short time between neoadjuvant
chemotherapy and surgery by the intervention. Such feasibility data is
required prior to a full randomised controlled trial investigating whether
my-PEP can reduce the incidence of postoperative complications.
Acknowledgements
The author would like to thank Dr S. Lam for the valuable contribution
he has made to the manuscript.
REFERENCES
American Thoracic Society. (2002). American Thoracic Society statement
guidelines for the six-minute walk test. American Journal of Respiratory and
Critical Care Medicine, 166, 111-117. doi: 10.1164/ajrccm.166.1.at1102
Barker, F., Atkins, L., & Lusignan, S. (2016). Applying the COMB behaviour
model and behaviour change wheel to develop an intervention to improve
hearing aid use in adult auditory rehabilitation. International Journal of
Audiology, 55(Suppl. 3), S90-S98, doi: 10.3109/14992027.2015.1120894
568
MELHORAR O BEM-ESTAR GLOBAL ATRAVÉS DA PSICOLOGIA DA SAÚDE
Best, L., Mughal, M., & Gurusamy, K. (2016). Non‐surgical versus surgical
treatment for oesophageal cancer. Cochrane Database of Systematic Reviews,
3, 1-59. doi: 10.1002/14651858.CD011498.pub2.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R., Torre, L., & Jemal, A. (2018).
Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal
for Clinicians, 68(6), 394-424. doi: 10.3322/caac.21492.
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M.
(2008). Developing and evaluating complex interventions: The new Medical
Research Council guidance. BMJ, 337, a1655. doi: 10.1136/bmj.a1655
Doganay, E., & Moorthy, K. (2019). Prehabilitation for esophagectomy. Journal
of thoracic disease, 11(Suppl. 5), S632-S638. doi:10.21037/jtd.2019.02.12
Glanz, K., & Bishop, D. B. (2010). The role of behavioral science theory in
development and implementation of public health interventions. Annual
Review of Public Health, 31, 399-418. doi: 10.1146/annurev.publhealth.
012809.103604
Lam, S. (2018). Physical activity in the aetiology and preoperative management
of oesophageal adenocarcinoma (MD thesis). Norwich Medical School at
University of East Anglia, Norwich (UK).
McEvoy, C., Moore, S., Appleton, K., Cupples, M., Erwin, C., Kee, F., . . .
Woodside, J. (2018). Development of a peer support intervention to
encourage dietary behaviour change towards a Mediterranean diet in adults at
high cardiovascular risk. BMC Public Health, 18, 1194. doi: 10.1186/s12889-
018-6108-z
Michie, S., Atkins, L., West, R. (2014). The behaviour change wheel: A guide to
designing interventions. London, UK: Silverback Publishing.
Michie, S., Campbell, R., West, R., Brown, J., & Gainforth, H. (2014). ABC of
Behaviour Change Theories. London, UK: Silverback Publishing.
Michie, S., & Wood, C. (2015). Health behaviour change techniques. In M.
Conner, & P. Norman (Eds.), Predicting and changing health behaviour:
Research and practice with social cognition models (3rd ed., pp. 359-389).
Maidenhead, UK: Open University Press. 
Ogden, J. (2016). Theories, timing and choice of audience: some key tensions in
health psychology and a response to commentaries on Ogden (2016). Health
Psychology Review, 10(3), 274-276. doi: 10.1080/17437199.2016.1190295
Oxenberg, J. (2018). Prevention and management of complications from
esophagectomy. In J. Chai (Ed.), Esophageal cancer and beyond, (pp. 29-46).
London, UK: InterchOpen. doi: 10.5772/intechopen.78757
13º CONGRESSO NACIONAL DE PSICOLOGIA DA SAÚDE
569
Rivera-Brown, A., & Frontera, W. (2012). Principles of exercise physiology:
Responses to acute exercise and long-term adaptations to training. PM&R,
4(11), 797-804. doi: 10.1016/j.pmrj.2012.10.007
Vermillion, S., James, A., Dorrell, R., Brubaker, P., Mihalko, S., Hill, A., & Clark,
C. (2018). Preoperative exercise therapy for gastrointestinal cancer patients: A
systematic review. Systematic reviews, 7, 103. doi:10.1186/s13643-018-0771-0
Wynter-Blyth, V., & Moorthy, K. (2017). Prehabilitation: Preparing patients for
surgery. BMJ, 358, 3702. doi: 10.1136/bmj.j3702
570
MELHORAR O BEM-ESTAR GLOBAL ATRAVÉS DA PSICOLOGIA DA SAÚDE
